Caricamento...
Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?
Assessing progression of disease or response to treatment remains a major challenge in the clinical management of nontuberculous mycobacterial (NTM) infections of the lungs. Serial assessments of validated measures of treatment response address whether the current therapeutic approach is on track to...
Salvato in:
| Pubblicato in: | Front Microbiol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6256187/ https://ncbi.nlm.nih.gov/pubmed/30524407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2018.02813 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|